|
BIOCRATES LIFE SCIENCES AG
|
| On this site you find detailed information about
companies and institutions active in the Biotechnology (Biotech), Medical Technology (Medtech)
or Pharmaceutical (Pharma) industries, such as BIOCRATES Life Sciences AG. The Database informs you
about the product pipeline of a company, about financing rounds, investors, the technology
platform used etc. You can click on the company name below to see more detailed information. |
Biomarker Diagnostics: The business unit works on the identification, validation and commercialization of metabolic biomarkers for diagnostic products developed in house or with strong partners. Biocrates focuses on indications with high medical need and attractive commercial potential, e.g. chronic kidney nephropathy or metabolic syndrome/Type II diabetes. Based on significant business collaborations with large pharmaceutical companies, BIOCRATES is also developing specific drug biomarkers for companion diagnostics to further leverage its unique technology.
TargetIDQ™ Services: Contract research services supports customers in identifying and quantifying hundreds of metabolites from a broad range of samples, ultimately revealing meaningful biomarkers.
AbsoluteIDQ™ Kit: Launched in 2008 as first metabolomic kit of its kind it enables quick, accurate detection and quantification of over 160 metabolites from four classes from only 10 microliters of plasma.
|
